Effective treatment of severe hypertensive crisis in 2-year-old child with neuroblastoma
Journal Title: OncoReview - Year 2015, Vol 5, Issue 2
Abstract
We describe a case of a 2-year-old boy with neuroblastoma and high catecholamine levels which developed a severe hypertensive crisis. An oral propranolol and oral angiotensin-converting enzyme inhibitor were used with a mild short transient benefit. However, an intravenous labetalol and oral doxazosin used for over 3 weeks resulted in successful blood pressure control. This report highlights the prolonged use of α and β-adrenergic antagonist therapy in children with neuroblastoma with refractory catecholamine-induced hypertension.
Authors and Affiliations
Anna Raciborska, Katarzyna Bilska, Jolanta Antoniewicz, Magdalena Rychłowska-Pruszyńska, Carlos Rodriguez-Galindo
Keywords
Related Articles
- EP ID EP67779
- DOI -
- Views 203
- Downloads 0
Central venous catheters and complications in cancer patients
Vascular access has great importance in the treatment of patients submitted to prolonged chemotherapy. We report two patients with early and late complications related to the presence of a central venous catheter. The fi...
Rehabilitation of patients with cancer of the respiratory system
Many patients with lung cancer have concomitant chronic obstructive pulmonary disease and heart diseases. The planned anticancer therapy should be individualized in relationship of patient’s cardiac and pulmonary conditi...
Advanced or metastatic non-small-cell lung cancer treatment - new Polish goverment regulation
The article presents the non-small-cell lung cancer current treatment recommendations in consideration of Polish government regulation.
Application of echocardiography in oncology – practical remarks
The paper presents the contemporary use of echocardiography in diagnosis of primary and metastatic tumors of the heart as well as in assessment of cardiovascular risk related to medical and interventional oncological the...
Rola eksemestanu w leczeniu raka piersi
Leczenie hormonalne jest jedną z podstawowych opcji terapeutycznych w leczeniu raka piersi, zarówno miejscowo zaawansowanego, jak i przerzutowego. Standardem od wielu lat pozostaje tamoksyfen, jednak wyniki nowych badań...